Search

everythinglearnresearchcommunity

for

Search:↓

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

JAK inhibitors like tofacitinib are effective and safer for severe alopecia areata than glucocorticosteroids.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

The new gel effectively treats psoriasis with minimal side effects.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Dupilumab can both trigger and treat alopecia areata, often leading to hair regrowth.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.

New cytokine-targeted therapies show promise for treating alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Methylprednisolone helps skin cells stick together better in pemphigus vulgaris.